{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:50:13Z","timestamp":1791665413216,"version":"4.3.4"},"reference-count":393,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["0301050405P0781"],"award-info":[{"award-number":["0301050405P0781"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.semcancer.2026.102622","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:14:16Z","timestamp":1790810056000},"page":"102622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RNA modifications and metabolism in cancer: Mechanisms, cross-talk and therapeutic implications"],"prefix":"10.1016","volume":"127","author":[{"given":"Xin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingke","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.molcel.2017.11.002","article-title":"Transcriptome-wide analysis of roles for tRNA modifications in translational regulation","volume":"68","author":"Chou","year":"2017","journal-title":"Mol. Cell."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/bfgp\/elaa024","article-title":"Deciphering RNA modifications at base resolution: from chemistry to biology","volume":"20","author":"Debnath","year":"2021","journal-title":"Brief. Funct. Genom."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102622_bib3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA modifications in gene expression regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.semcancer.2026.102622_bib4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/0109298665310091240809103048","article-title":"Macromolecular polymer based complexes: a diverse strategy for the delivery of nucleotides","volume":"31","author":"Singh","year":"2024","journal-title":"Protein Pept. Lett."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrg.2016.169","article-title":"Detecting RNA modifications in the epitranscriptome: predict and validate","volume":"18","author":"Helm","year":"2017","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2174\/0113892029288843240402042529","article-title":"Detection and quantification of 5moU RNA modification from direct RNA sequencing data","volume":"25","author":"Li","year":"2024","journal-title":"Curr. Genom."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/0113892029296712240405053201","article-title":"Ramifications of m\u2076A modification on ncRNAs in cancer","volume":"25","author":"Mehmood","year":"2024","journal-title":"Curr. Genom."},{"key":"10.1016\/j.semcancer.2026.102622_bib8","article-title":"RNA modification systems as therapeutic targets","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib9","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1038\/s41467-024-47953-7","article-title":"Prediction of m\u2076A and m\u2075C at single-molecule resolution reveals a transcriptome-wide co-occurrence of RNA modifications","volume":"15","author":"Acera Mateos","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.102622_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semcancer.2024.12.002","article-title":"Theoretical framework and emerging challenges of lipid metabolism in cancer","volume":"108","author":"Gu","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.421","article-title":"Potential therapies targeting nuclear metabolic regulation in cancer","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.semcancer.2026.102622_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcancer.2025.12.003","article-title":"Leveraging cancer metabolism to translate into effective therapeutics","volume":"118","author":"Xu","year":"2026","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2026.102622_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2025.02.003","article-title":"Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging","volume":"111","author":"Fang","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"Pt 3","key":"10.1016\/j.semcancer.2026.102622_bib14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semcancer.2022.02.010","article-title":"Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer","volume":"86","author":"Wang","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s42255-022-00568-y","article-title":"Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth","volume":"4","author":"Cheng","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.semcancer.2026.102622_bib16","article-title":"Metabolism of amino acids in cancer","volume":"8","author":"Wei","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib17","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1038\/s41467-025-60115-7","article-title":"hnRNPL phase separation activates PIK3CB transcription and promotes glycolysis in ovarian cancer","volume":"16","author":"Qin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.102622_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1158467","article-title":"Editorial: tumor metabolism: from molecular mechanisms to clinical application","volume":"11","author":"Cheng","year":"2023","journal-title":"Front. Cell. Dev. Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2015.09.021","article-title":"Glucose-mediated N-glycosylation of SCAP Is Essential for SREBP-1 activation and tumor growth","volume":"28","author":"Cheng","year":"2015","journal-title":"Cancer Cell."},{"issue":"8","key":"10.1016\/j.semcancer.2026.102622_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102429","article-title":"Targeting SMOX for the treatment of hepatocellular carcinoma?","volume":"48","author":"Tao","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2174\/0109298665330728241025082011","article-title":"Recent trends in development of novel therapeutics for modulation of 14-3-3 protein-protein interactions in diseases","volume":"31","author":"Nazir","year":"2024","journal-title":"Protein Pept. Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43556-023-00139-x","article-title":"RNA modification: mechanisms and therapeutic targets","volume":"4","author":"Qiu","year":"2023","journal-title":"Mol. Biomed."},{"issue":"22","key":"10.1016\/j.semcancer.2026.102622_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213851","article-title":"Epitranscriptome: Review of Top 25 Most-Studied RNA Modifications","volume":"23","author":"Arzumanian","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70190","article-title":"Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives","volume":"15","author":"Jia","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/cr.2014.143","article-title":"Pseudouridine in a new era of RNA modifications","volume":"25","author":"Zhao","year":"2015","journal-title":"Cell. Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib26","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1038\/s41467-025-62981-7","article-title":"Chemically modified tRNA enhances the translation capacity of mRNA rich in cognate codons","volume":"16","author":"Dong","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41576-022-00501-9","article-title":"tRNA dysregulation and disease","volume":"23","author":"Orellana","year":"2022","journal-title":"Nat. Rev. Genet."},{"issue":"6409","key":"10.1016\/j.semcancer.2026.102622_bib28","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.aau1646","article-title":"RNA modifications modulate gene expression during development","volume":"361","author":"Frye","year":"2018","journal-title":"Science (New York N. Y. )"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41576-023-00645-2","article-title":"RNA modifications in physiology and disease: towards clinical applications","volume":"25","author":"Delaunay","year":"2024","journal-title":"Nat. Rev. Genet."},{"issue":"6292","key":"10.1016\/j.semcancer.2026.102622_bib30","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1126\/science.aad8711","article-title":"Messenger RNA modifications: Form, distribution, and function","volume":"352","author":"Gilbert","year":"2016","journal-title":"Science (New York N. Y. )"},{"key":"10.1016\/j.semcancer.2026.102622_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fbioe.2018.00008","article-title":"The Role of Noncoding RNA Pseudouridylation in Nuclear Gene Expression Events","volume":"6","author":"Zhao","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkn1038","article-title":"Scintillation proximity assay for measurement of RNA methylation","volume":"37","author":"Baker","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib33","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41467-023-35858-w","article-title":"Semi-quantitative detection of pseudouridine modifications and type I\/II hypermodifications in human mRNAs using direct long-read sequencing","volume":"14","author":"Tavakoli","year":"2023","journal-title":"Nat. Commun."},{"issue":"7679","key":"10.1016\/j.semcancer.2026.102622_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature24456","article-title":"The m\u00b9A landscape on cytosolic and mitochondrial mRNA at single-base resolution","volume":"551","author":"Safra","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.102622_bib35","doi-asserted-by":"crossref","unstructured":"M. Bansal, A. Kundu, A. Gupta, J. Ding, A. Gibson, S.V. RudraRaju, S. Sudarshan, H.F. Ding, Integrative analysis of nanopore direct RNA sequencing data reveals a role of PUS7-dependent pseudouridylation in regulation of m (6) A and m (5) C modifications, npj Precis. Onc. 10 (52) (2026).","DOI":"10.1038\/s41698-026-01278-4"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm.2015.4","article-title":"A-to-I editing of coding and non-coding RNAs by ADARs","volume":"17","author":"Nishikura","year":"2016","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib37","doi-asserted-by":"crossref","first-page":"9450","DOI":"10.1038\/s41467-025-64495-8","article-title":"DirectRM: integrated detection of landscape and crosstalk between multiple RNA modifications using direct RNA sequencing","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.102622_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-1-4939-6807-7_5","article-title":"Mapping m(6)A at Individual-Nucleotide Resolution Using Crosslinking and Immunoprecipitation (miCLIP)","volume":"1562","author":"Grozhik","year":"2017","journal-title":"Methods Mol. Biol. (Clifton N. J. )"},{"key":"10.1016\/j.semcancer.2026.102622_bib39","doi-asserted-by":"crossref","unstructured":"J. Zhou, Z. Wei, D. Zhen, Y. Wang, J. Su, F. Coenen, G. Jia, D.J. Rigden, J. Meng, Comprehensive Epitranscriptome Analysis from MeRIP-seq Data with exomePeak2, Genomics, proteomics & bioinformatics (2026).","DOI":"10.1093\/gpbjnl\/qzag019"},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cell.2022.02.007","article-title":"The epitranscriptome toolbox","volume":"185","author":"Moshitch-Moshkovitz","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.102622_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-0716-4071-5_13","article-title":"Integrative Analysis of CUT&Tag and RNA-Seq Data Through Bioinformatics: A Unified Workflow for Enhanced Insights","volume":"2846","author":"Liorni","year":"2024","journal-title":"Methods Mol. Biol. (Clifton N. J. )"},{"key":"10.1016\/j.semcancer.2026.102622_bib42","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.csbj.2020.06.010","article-title":"Bioinformatics approaches for deciphering the epitranscriptome: Recent progress and emerging topics","volume":"18","author":"Liu","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab309","article-title":"Differential RNA methylation using multivariate statistical methods","volume":"23","author":"Ayyala","year":"2022","journal-title":"Brief. Bioinforma."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41392-022-01003-0","article-title":"Role of main RNA modifications in cancer: N(6)-methyladenosine, 5-methylcytosine, and pseudouridine","volume":"7","author":"Xue","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tig.2022.10.004","article-title":"Genetic and epigenetic defects of the RNA modification machinery in cancer","volume":"39","author":"Orsolic","year":"2023","journal-title":"Trends genetics TIG"},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib46","first-page":"313","article-title":"The dynamic epitranscriptome: N\u2076-methyladenosine and gene expression control, Nature reviews","volume":"15","author":"Meyer","year":"2014","journal-title":"Mol. Cell. Biol."},{"issue":"23","key":"10.1016\/j.semcancer.2026.102622_bib47","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acs.accounts.3c00448","article-title":"Emerging Roles of RNA Methylation in Development","volume":"56","author":"Wang","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib48","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1038\/s41467-021-26718-6","article-title":"N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib49","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.7150\/ijbs.104407","article-title":"The Mechanism and Latest Progress of m\u2076A Methylation in the Progression of Pancreatic Cancer","volume":"21","author":"Liu","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102622_bib50","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/cac2.12161","article-title":"N(6) -methyladenosine Steers RNA Metabolism and Regulation in Cancer","volume":"41","author":"Dong","year":"2021","journal-title":"Cancer communications (London England)"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib51","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41556-023-01258-x","article-title":"O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins","volume":"25","author":"Chen","year":"2023","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.semcancer.2026.102622_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70055","article-title":"METTL5-mediated 18S rRNA mA modification enhances ribosome assembly and ABA response in Arabidopsis","volume":"4","author":"Li","year":"2025","journal-title":"iMeta"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-020-00510-w","article-title":"METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m\u2076A-dependent manner","volume":"53","author":"Pan","year":"2021","journal-title":"Exp. & Mol. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib54","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13045-021-01204-0","article-title":"N\u2076-methyladenosine reader IMP2 stabilizes the ZFAS1\/OLA1 axis and activates the Warburg effect: implication in colorectal cancer","volume":"14","author":"Lu","year":"2021","journal-title":"J. Hematol. & Oncol."},{"key":"10.1016\/j.semcancer.2026.102622_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01415-6","article-title":"Crosstalk between N\u2076-methyladenosine modification and circular RNAs: current understanding and future directions","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.102622_bib56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-022-01620-x","article-title":"Mutual regulation between N\u2076-methyladenosine (m\u2076A) modification and circular RNAs in cancer: impacts on therapeutic resistance","volume":"21","author":"Lin","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40364-022-00362-8","article-title":"Biological roles of RNA m(5)C modification and its implications in Cancer immunotherapy","volume":"10","author":"Song","year":"2022","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib58","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1038\/s41467-021-24969-x","article-title":"Neuronal Nsun2 deficiency produces tRNA epitranscriptomic alterations and proteomic shifts impacting synaptic signaling and behavior","volume":"12","author":"Blaze","year":"2021","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.semcancer.2026.102622_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf995","article-title":"mRNA turnover dynamics are affected by cell differentiation and loss of the cytosine methyltransferase Nsun2","volume":"53","author":"Delazer","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"34","key":"10.1016\/j.semcancer.2026.102622_bib60","article-title":"NSUN5 Attenuates Renal Injury and Ferroptosis in Hyperuricaemic Nephropathy Through YBX2-Dependent Stabilisation of SCD1 m\u2075C Methylation","volume":"13","author":"Song","year":"2026","journal-title":"Advanced science (Weinheim Baden-Wurttemberg Germany)"},{"issue":"D1","key":"10.1016\/j.semcancer.2026.102622_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab1075","article-title":"m\u2075C-Atlas: a comprehensive database for decoding and annotating the 5-methylcytosine (m\u2075C) epitranscriptome","volume":"50","author":"Ma","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"15","key":"10.1016\/j.semcancer.2026.102622_bib62","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.7150\/ijbs.101337","article-title":"The Quiet Giant: Identification, Effectors, Molecular Mechanism, Physiological and Pathological Function in mRNA 5-methylcytosine Modification","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib63","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.7150\/ijbs.97503","article-title":"NOP2-mediated 5-methylcytosine modification of APOL1 messenger RNA activates PI3K-Akt and facilitates clear cell renal cell carcinoma progression","volume":"20","author":"Tian","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12964-023-01206-0","article-title":"Enhancer RNAs: mechanisms in transcriptional regulation and functions in diseases","volume":"21","author":"Li","year":"2023","journal-title":"Cell. Commun. Signal."},{"issue":"33","key":"10.1016\/j.semcancer.2026.102622_bib65","doi-asserted-by":"crossref","first-page":"11582","DOI":"10.1021\/ja505305z","article-title":"Tet-mediated formation of 5-hydroxymethylcytosine in RNA","volume":"136","author":"Fu","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib66","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1093\/nar\/gkx354","article-title":"ALKBH1 is an RNA dioxygenase responsible for cytoplasmic and mitochondrial tRNA modifications","volume":"45","author":"Kawarada","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.semcancer.2026.102622_bib67","doi-asserted-by":"crossref","DOI":"10.1021\/acs.accounts.3c00450","article-title":"Chemoproteomic Approaches to Studying RNA Modification-Associated Proteins","volume":"56","author":"Dai","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.semcancer.2026.102622_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.10.026","article-title":"Glycosylated queuosines in tRNAs optimize translational rate and post-embryonic growth","volume":"186","author":"Zhao","year":"2023","journal-title":"Cell"},{"issue":"36","key":"10.1016\/j.semcancer.2026.102622_bib69","doi-asserted-by":"crossref","first-page":"19592","DOI":"10.1002\/anie.202105253","article-title":"Programmable RNA N(1) -Methyladenosine Demethylation by a Cas13d-Directed Demethylase","volume":"60","author":"Xie","year":"2021","journal-title":"Angew. Chem. (Int. Ed. Engl. )"},{"key":"10.1016\/j.semcancer.2026.102622_bib70","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf813","article-title":"Evidence human FTO catalyses hydroxylation of N-methyladenosine without direct formation of a demethylated product contrasting with ALKBH5\/2\/3 and bacterial AlkB","volume":"53","author":"Kaur","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"19","key":"10.1016\/j.semcancer.2026.102622_bib71","doi-asserted-by":"crossref","first-page":"12074","DOI":"10.1093\/nar\/gkae796","article-title":"Combining Nanopore direct RNA sequencing with genetics and mass spectrometry for analysis of T-loop base modifications across 42 yeast tRNA isoacceptors","volume":"52","author":"Shaw","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib72","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.molcel.2025.02.003","article-title":"YTHDC1 cooperates with the THO complex to prevent RNA-damage-induced DNA breaks","volume":"85","author":"Tsao","year":"2025","journal-title":"Mol. Cell."},{"key":"10.1016\/j.semcancer.2026.102622_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01285-5","article-title":"The potential role of N\u2077-methylguanosine (m\u2077G) in cancer","volume":"15","author":"Luo","year":"2022","journal-title":"J. Hematol. & Oncol."},{"issue":"8046","key":"10.1016\/j.semcancer.2026.102622_bib74","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41586-024-08304-0","article-title":"Jr., The mechanism of mRNA cap recognition","volume":"637","author":"Gentry","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib75","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1038\/s41467-025-61775-1","article-title":"Chemical circularization of in vitro transcribed RNA for exploring circular mRNA design","volume":"16","author":"Wasinska-Kalwa","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib76","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1038\/s41467-024-49796-8","article-title":"Perturbation of METTL1-mediated tRNA N7- methylguanosine modification induces senescence and aging","volume":"15","author":"Fu","year":"2024","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.semcancer.2026.102622_bib77","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1016\/j.molcel.2023.08.014","article-title":"18S rRNA methyltransferases DIMT1 and BUD23 drive intergenerational hormesis","volume":"83","author":"Liberman","year":"2023","journal-title":"Mol. Cell."},{"issue":"15","key":"10.1016\/j.semcancer.2026.102622_bib78","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.molcel.2022.05.016","article-title":"Direct epitranscriptomic regulation of mammalian translation initiation through N\u2074-acetylcytidine","volume":"82","author":"Arango","year":"2022","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib79","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1038\/s41467-023-42135-3","article-title":"NAT10-dependent N(4)-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12964-023-01417-5","article-title":"Recent advances in the potential role of RNA N\u2074-acetylcytidine in cancer progression","volume":"22","author":"Zhang","year":"2024","journal-title":"Cell communication signaling CCS"},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads2923","article-title":"Transfer RNA acetylation regulates in vivo mammalian stress signaling","volume":"11","author":"Thalalla Gamage","year":"2025","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib82","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1093\/nar\/gkac404","article-title":"Probing small ribosomal subunit RNA helix 45 acetylation across eukaryotic evolution","volume":"50","author":"Bortolin-Cavaill\u00e9","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib83","first-page":"9","article-title":"Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression","volume":"42","author":"Deng","year":"2023","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"10","key":"10.1016\/j.semcancer.2026.102622_bib84","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41589-023-01304-7","article-title":"Quantitative profiling of pseudouridylation landscape in the human transcriptome","volume":"19","author":"Zhang","year":"2023","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41477-024-01894-7","article-title":"Quantitative RNA pseudouridine maps reveal multilayered translation control through plant rRNA, tRNA and mRNA pseudouridylation","volume":"11","author":"Li","year":"2025","journal-title":"Nat. Plants"},{"issue":"33","key":"10.1016\/j.semcancer.2026.102622_bib86","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg8190","article-title":"Regulation of translation by ribosomal RNA pseudouridylation","volume":"9","author":"Zhao","year":"2023","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib87","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41589-025-02025-9","article-title":"A \u03a8-\u03a8 codon-anticodon pairing in nonsense suppression and translational recoding","volume":"22","author":"Pan","year":"2026","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib88","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41556-025-01803-w","article-title":"A comprehensive tRNA pseudouridine map uncovers targets dependent on human stand-alone pseudouridine synthases","volume":"27","author":"Xu","year":"2025","journal-title":"Nat. Cell. Biol."},{"issue":"20","key":"10.1016\/j.semcancer.2026.102622_bib89","doi-asserted-by":"crossref","first-page":"11810","DOI":"10.1093\/nar\/gkab934","article-title":"The human pseudouridine synthase PUS7 recognizes RNA with an extended multi-domain binding surface","volume":"49","author":"Guegueniat","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib90","article-title":"Quantitative analysis of small RNA pseudouridylation reveals interplay of PUS enzymes in tRNA anticodon stem-loop","volume":"17","author":"Liu","year":"2026","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib91","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41592-024-02439-8","article-title":"Absolute quantitative and base-resolution sequencing reveals comprehensive landscape of pseudouridine across the human transcriptome","volume":"21","author":"Xu","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.semcancer.2026.102622_bib92","doi-asserted-by":"crossref","first-page":"D106","DOI":"10.1093\/nar\/gkac1061","article-title":"DirectRMDB: a database of post-transcriptional RNA modifications unveiled from direct RNA sequencing technology","volume":"51","author":"Zhang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.semcancer.2026.102622_bib93","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1038\/s41467-021-27393-3","article-title":"RNA modifications detection by comparative Nanopore direct RNA sequencing","volume":"12","author":"Leger","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib94","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the Intersections between Metabolism and Cancer Biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2026.102622_bib95","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","article-title":"Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention","volume":"159","author":"Butler","year":"2020","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib96","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat. Cell. Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib97","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell."},{"issue":"46","key":"10.1016\/j.semcancer.2026.102622_bib98","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409509121","article-title":"The Warburg Effect is the result of faster ATP production by glycolysis than respiration","volume":"121","author":"Kukurugya","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.102622_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114181","article-title":"Hyperbaric oxygen augments Doxil antitumor efficacy by reducing tumor-induced lactate","volume":"387","author":"Li","year":"2025","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine Metabolism in Cancer: Understanding the Heterogeneity","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib102","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: Still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell. Metab."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib103","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/brv.12140","article-title":"The return of metabolism: biochemistry and physiology of the pentose phosphate pathway","volume":"90","author":"Stincone","year":"2015","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.122","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp. & Mol. Med."},{"key":"10.1016\/j.semcancer.2026.102622_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"issue":"21","key":"10.1016\/j.semcancer.2026.102622_bib107","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-20-3242","article-title":"Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer","volume":"81","author":"Evans","year":"2021","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102622_bib108","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: New perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev. Cell."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib109","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41419-019-1532-2","article-title":"Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma","volume":"10","author":"Sun","year":"2019","journal-title":"Cell. death & Dis."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell. Metab."},{"issue":"21","key":"10.1016\/j.semcancer.2026.102622_bib111","article-title":"Fatty Acid Oxidation Supports Lymph Node Metastasis of Cervical Cancer via Acetyl-CoA-Mediated Stemness","volume":"11","author":"Yuan","year":"2024","journal-title":"Advanced science (Weinheim Baden-Wurttemberg Germany)"},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib112","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41419-022-04730-y","article-title":"CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma","volume":"13","author":"Tang","year":"2022","journal-title":"Cell. death & Dis."},{"key":"10.1016\/j.semcancer.2026.102622_bib113","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: An emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102622_bib114","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.15252\/embj.201696151","article-title":"Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine","volume":"36","author":"Zhang","year":"2017","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbcan.2018.07.007","article-title":"Glutaminase isoenzymes in the metabolic therapy of cancer","volume":"1870","author":"Mat\u00e9s","year":"2018","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib116","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","article-title":"New aspects of amino acid metabolism in cancer","volume":"122","author":"Vettore","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib117","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s13238-017-0451-1","article-title":"The emerging role and targetability of the TCA cycle in cancer metabolism","volume":"9","author":"Anderson","year":"2018","journal-title":"Protein & Cell."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib118","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1158\/0008-5472.CAN-24-3477","article-title":"Blocking the TCA Cycle in Cancer Cells Potentiates CD36+ T-cell-Mediated Antitumor Immunity by Suppressing ER Stress-Associated THBS2 Signaling","volume":"85","author":"Yang","year":"2025","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib119","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","article-title":"The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate","volume":"17","author":"Ward","year":"2010","journal-title":"Cancer Cell."},{"issue":"7443","key":"10.1016\/j.semcancer.2026.102622_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib121","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib122","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cell.2011.03.044","article-title":"Nucleotide deficiency promotes genomic instability in early stages of cancer development","volume":"145","author":"Bester","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib123","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.gendis.2022.11.022","article-title":"Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer","volume":"11","author":"Zuo","year":"2024","journal-title":"Genes. & Dis."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib124","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-021-00250-z","article-title":"DHODH and cancer: promising prospects to be explored","volume":"9","author":"Zhou","year":"2021","journal-title":"Cancer & Metab."},{"issue":"6274","key":"10.1016\/j.semcancer.2026.102622_bib125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1126\/science.aac6054","article-title":"Spatial colocalization and functional link of purinosomes with mitochondria","volume":"351","author":"French","year":"2016","journal-title":"Science (New York N. Y. )"},{"issue":"7558","key":"10.1016\/j.semcancer.2026.102622_bib126","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature14351","article-title":"MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis","volume":"523","author":"Koh","year":"2015","journal-title":"Nature"},{"issue":"5951","key":"10.1016\/j.semcancer.2026.102622_bib127","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1126\/science.1172156","article-title":"AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation","volume":"326","author":"Lamia","year":"2009","journal-title":"Science (New York N. Y. )"},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib128","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"17","key":"10.1016\/j.semcancer.2026.102622_bib129","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1016\/j.molcel.2022.08.004","article-title":"The Warburg effect: Saturation of mitochondrial NADH shuttles triggers aerobic lactate fermentation","volume":"82","author":"Medeiros","year":"2022","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib130","first-page":"340","article-title":"AMPK-HIF-1\u03b1 signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth","volume":"42","author":"Yun","year":"2023","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"22","key":"10.1016\/j.semcancer.2026.102622_bib131","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178617","article-title":"Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells","volume":"134","author":"Shen","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"7901","key":"10.1016\/j.semcancer.2026.102622_bib132","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-022-04475-w","article-title":"A non-canonical tricarboxylic acid cycle underlies cellular identity","volume":"603","author":"Arnold","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib133","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.molcel.2025.12.001","article-title":"Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer","volume":"86","author":"Zhu","year":"2026","journal-title":"Mol. Cell."},{"key":"10.1016\/j.semcancer.2026.102622_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101870","article-title":"Mitochondrial metabolism-mediated redox regulation in cancer progression","volume":"42","author":"Boese","year":"2021","journal-title":"Redox Biol."},{"issue":"679","key":"10.1016\/j.semcancer.2026.102622_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq6288","article-title":"Targeting de novo lipid synthesis induces lipotoxicity and impairs DNA damage repair in glioblastoma mouse models","volume":"15","author":"Eyme","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib136","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201400","article-title":"ZBTB18 inhibits SREBP-dependent lipid synthesis by halting CTBPs and LSD1 activity in glioblastoma","volume":"6","author":"Ferrarese","year":"2023","journal-title":"Life Sci. Alliance"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib137","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12944-023-01881-5","article-title":"Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities","volume":"22","author":"Kao","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.semcancer.2026.102622_bib138","article-title":"Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma","volume":"5","author":"Zhong","year":"2024","journal-title":"Cell. Rep. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib139","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12964-023-01449-x","article-title":"Glutamine addiction in tumor cell: oncogene regulation and clinical treatment","volume":"22","author":"Li","year":"2024","journal-title":"Cell communication signaling CCS"},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib140","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/CM9.0000000000002758","article-title":"Pancreatic ductal adenocarcinoma chemoresistance: From metabolism reprogramming to novel treatment","volume":"137","author":"Zhang","year":"2024","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib141","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","article-title":"Targeting pancreatic cancer metabolic dependencies through glutamine antagonism","volume":"5","author":"Encarnaci\u00f3n-Rosado","year":"2024","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib142","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12943-020-01190-w","article-title":"m(6)A-dependent glycolysis enhances colorectal cancer progression","volume":"19","author":"Shen","year":"2020","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib143","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","article-title":"RNA N(6)-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m(6)A-GLUT1-mTORC1 Axis and Is a Therapeutic Target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib144","first-page":"267","article-title":"LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N\u2076-methyladenosine modification on GLUT1 and PKM2","volume":"42","author":"Wang","year":"2023","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib145","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.7150\/ijbs.86658","article-title":"The m\u2076A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma","volume":"20","author":"Zeng","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib146","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s11658-024-00622-5","article-title":"N(6)-methyladenosine-modified SRPK1 promotes aerobic glycolysis of lung adenocarcinoma via PKM splicing","volume":"29","author":"Wang","year":"2024","journal-title":"Cell. & Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113149","article-title":"METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1\/c-Myc axis","volume":"416","author":"Liu","year":"2022","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.semcancer.2026.102622_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101583","article-title":"Linc-UROD stabilizes ENO1 and PKM to strengthen glycolysis, proliferation and migration of pancreatic cancer cells","volume":"27","author":"He","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.semcancer.2026.102622_bib149","article-title":"N\u2076-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells, Drug resistance updates: reviews and commentaries in antimicrobial and anticancer","volume":"65","author":"Liu","year":"2022","journal-title":"chemotherapy"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12885-025-13532-2","article-title":"Up-regulation of m(6)A writer METTL14 inhibits tumorigenesis by suppressing glycolysis in colorectal cancer","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib151","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41420-024-02133-w","article-title":"METTL14-mediated m\u2076A mRNA modification of G6PD promotes lung adenocarcinoma","volume":"10","author":"Wu","year":"2024","journal-title":"Cell. death Discov."},{"key":"10.1016\/j.semcancer.2026.102622_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216840","article-title":"Glycolysis and tumor progression promoted by the m(6)A writer VIRMA via m(6)A-dependent upregulation of STRA6 in pancreatic ductal adenocarcinoma","volume":"590","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib153","first-page":"42","article-title":"FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N\u2076-methyladenosine-dependent manner","volume":"41","author":"Huang","year":"2022","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib154","first-page":"36","article-title":"The essential roles of m(6)A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma","volume":"41","author":"Ma","year":"2022","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"21","key":"10.1016\/j.semcancer.2026.102622_bib155","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1158\/0008-5472.CAN-22-0800","article-title":"ALKBH5-Mediated m\u2076A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib156","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/mc.23609","article-title":"USF1-mediated ALKBH5 stabilizes FLII mRNA in an m\u2076A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma","volume":"62","author":"Fu","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.semcancer.2026.102622_bib157","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.omtn.2020.10.031","article-title":"ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m\u2076A-CK2\u03b1-Mediated Glycolysis","volume":"23","author":"Yu","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib158","first-page":"330","article-title":"UBR7 inhibits HCC tumorigenesis by targeting Keap1\/Nrf2\/Bach1\/HK2 and glycolysis","volume":"41","author":"Zhao","year":"2022","journal-title":"Journal experimental & clinical cancer research CR"},{"key":"10.1016\/j.semcancer.2026.102622_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101745","article-title":"m(6)A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis","volume":"36","author":"Xu","year":"2023","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41419-022-04711-1","article-title":"YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis","volume":"13","author":"Yao","year":"2022","journal-title":"Cell. death & Dis."},{"key":"10.1016\/j.semcancer.2026.102622_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117097","article-title":"Histone lactylation-driven YTHDF2 promotes non-small cell lung cancer cell glycolysis and stemness by recognizing m\u2076A modification of SFRP2","volume":"240","author":"Zhao","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.semcancer.2026.102622_bib162","article-title":"METTL14-mediated m\u2076A modification of ETV4 inhibits tumor development in colorectal cancer","volume":"831","author":"Liao","year":"2025","journal-title":"Mutat. Res."},{"issue":"8","key":"10.1016\/j.semcancer.2026.102622_bib163","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1007\/s00432-022-04337-y","article-title":"N(6)-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability","volume":"149","author":"Liu","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113176","article-title":"N(6)-methyladenosine (m(6)A) reader IGF2BP1 accelerates gastric cancer aerobic glycolysis in c-Myc-dependent manner","volume":"417","author":"Luo","year":"2022","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.semcancer.2026.102622_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1480834","article-title":"IGF2BP1 accelerates the aerobic glycolysis to boost its immune escape in hepatocellular carcinoma microenvironment","volume":"15","author":"Ye","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102622_bib166","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/cbin.11856","article-title":"WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma","volume":"46","author":"Qin","year":"2022","journal-title":"Cell. Biol. Int."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib167","doi-asserted-by":"crossref","DOI":"10.3892\/or.2025.9002","article-title":"m\u2076A reader IGF2BP2 mediates paclitaxel resistance in esophageal squamous cell carcinoma via FOXM1 mRNA stabilization","volume":"54","author":"Ren","year":"2025","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib168","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41420-021-00674-y","article-title":"m(6)A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability","volume":"7","author":"Liu","year":"2021","journal-title":"Cell. death Discov."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib169","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s11658-025-00781-z","article-title":"NSUN2-tRNA(Val-CAC)-axis-regulated codon-biased translation drives triple-negative breast cancer glycolysis and progression","volume":"30","author":"Wang","year":"2025","journal-title":"Cell. & Mol. Biol. Lett."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib170","first-page":"616","article-title":"The NSUN2-YBX1 axis enhances 5-Methylcytosine modification to facilitate NPM1-mediated nuclear translocation of PKM2, augmenting the Warburg effect and promoting nasopharyngeal carcinoma progression in a mouse model","volume":"63","author":"Wang","year":"2025","journal-title":"Rhinology"},{"issue":"4-5","key":"10.1016\/j.semcancer.2026.102622_bib171","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10863-025-10062-1","article-title":"NSUN2 contributes to the RB malignant progression and Glycolysis by mediating the m\u2075C methylation modification of HKDC1","volume":"57","author":"Guan","year":"2025","journal-title":"J. Bioenerg. Biomembr."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102622_bib172","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/cac2.70023","article-title":"Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2-mediated increase of SOAT2 RNA methylation","volume":"45","author":"Jiang","year":"2025","journal-title":"Cancer communications (London England)"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib173","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1186\/s12885-025-14714-8","article-title":"NSUN5 accelerates the progression of liver hepatocellular carcinoma by m\u2075C-EFNA3-mediated glycolysis","volume":"25","author":"Han","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2026.102622_bib174","first-page":"0184","article-title":"NOP2-mediated m\u2075C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression","volume":"6","author":"Zhang","year":"2023","journal-title":"Res. (Wash. D. C. )"},{"issue":"7","key":"10.1016\/j.semcancer.2026.102622_bib175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cac2.12158","article-title":"The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer communications (London England)"},{"key":"10.1016\/j.semcancer.2026.102622_bib176","doi-asserted-by":"crossref","unstructured":"H. Li, Y. Liang, J. Tang, H. Luo, Y. Wang, YBX1 Enhances the Stability of TM4SF1 in an m\u2075C-Dependent Manner to Promote Bladder Cancer Proliferation and Glycolysis, Comb Chem High Throughput Screen. 29(14) (2026) 2061-2074.","DOI":"10.2174\/0113862073392269250825105059"},{"issue":"28","key":"10.1016\/j.semcancer.2026.102622_bib177","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119038119","article-title":"RNA m(1)A methylation regulates glycolysis of cancer cells through modulating ATP5D","volume":"119","author":"Wu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib178","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1016\/j.apsb.2025.04.018","article-title":"ALKBH3-regulated m(1)A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells","volume":"15","author":"Deng","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib179","first-page":"538","article-title":"N\u2077-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma","volume":"13","author":"Xu","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib180","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1186\/s12967-024-05991-1","article-title":"METTL1 mediates PKM m\u2077G modification to regulate CD155 expression and promote immune evasion in colorectal cancer","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.102622_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156174","article-title":"METTL1 drives glioma progression by promoting N\u2077-methylguanosine (m\u2077G) modification of glycolysis-related enzyme PGK1","volume":"274","author":"Fan","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.semcancer.2026.102622_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156102","article-title":"METTL1 mediates m\u2077G modification of PFKFB3 mRNA to promote radioresistance in esophageal cancer by affecting glycolytic metabolism","volume":"272","author":"Xiao","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib183","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12890-024-03463-2","article-title":"Role of NAT10-mediated ac(4)C acetylation of ENO1 mRNA in glycolysis and apoptosis in non-small cell lung cancer cells","volume":"25","author":"Yuan","year":"2025","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib184","article-title":"NAT10 promotes glycolysis and cell stemness of ovarian cancer cells via ac\u2074C acetylation of PGAM1 mRNA","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2026.102622_bib185","article-title":"NAT10-mediated N4-acetylcytosine modification promotes the progression of retinoblastoma by improving the HK1 mRNA stability to enhance glycolysis","volume":"80","author":"Xu","year":"2025","journal-title":"Clin. (Sao Paulo Braz. )"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib186","article-title":"NAT10 contributes to the progression of multiple myeloma through ac\u2074C modification of GPR37","volume":"30","author":"Liu","year":"2025","journal-title":"Hematol. (Amst. Neth. )"},{"issue":"23","key":"10.1016\/j.semcancer.2026.102622_bib187","article-title":"N\u2074-acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10\/SEPT9\/HIF-1\u03b1 Positive Feedback Loop","volume":"10","author":"Yang","year":"2023","journal-title":"Advanced science (Weinheim Baden-Wurttemberg Germany)"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib188","first-page":"278","article-title":"NAT10\/ac\u2074C\/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction","volume":"43","author":"Li","year":"2024","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib189","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12964-023-01321-y","article-title":"NAT10 mediated ac\u2074C acetylation driven m(6)A modification via involvement of YTHDC1-LDHA\/PFKM regulates glycolysis and promotes osteosarcoma","volume":"22","author":"Mei","year":"2024","journal-title":"Cell communication signaling CCS"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.urolonc.2020.06.026","article-title":"Pseudouridine as a novel biomarker in prostate cancer","volume":"39","author":"Stockert","year":"2021","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.semcancer.2026.102622_bib191","article-title":"The functions and mechanisms of RNA modification in prostate: Current status and future perspectives","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102622_bib192","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1007\/s11010-025-05267-2","article-title":"PUS7 promotes the progression of pancreatic cancer by interacting ANLN to activate MYC pathway","volume":"480","author":"Jiang","year":"2025","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib193","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat","volume":"5","author":"Dong","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102622_bib194","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/jgh.16988","article-title":"The METTL14-YTHDF1-SAP30 Axis Promotes Glycolysis and Oxaliplatin Resistance in Colorectal Adenocarcinoma via m\u2076A Modification","volume":"40","author":"Zhang","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10565-024-09904-2","article-title":"KIAA1429 increases FOXM1 expression through YTHDF1-mediated m\u2076A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma","volume":"40","author":"Wu","year":"2024","journal-title":"Cell. Biol. Toxicol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib196","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-023-04741-8","article-title":"lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m\u2076A-dependent glycolysis and promoting the polarization of tumor-associated macrophages","volume":"80","author":"Ye","year":"2023","journal-title":"Cell. Mol. life Sci. CMLS"},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib197","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41435-025-00336-4","article-title":"Integrative multi-omics reveal NSUN2 facilitates glycolysis and histone lactylation-driven immune evasion in renal carcinoma","volume":"26","author":"Wang","year":"2025","journal-title":"Genes. Immun."},{"key":"10.1016\/j.semcancer.2026.102622_bib198","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.996329","article-title":"Integrative proteomics and m\u2076A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"issue":"20","key":"10.1016\/j.semcancer.2026.102622_bib199","article-title":"FOXO6, Stabilized by METTL3-Mediated m\u2076A Modification, Accelerates Polycystic Ovary Syndrome Progression by Transcriptional Activation of TXNIP","volume":"39","author":"Sui","year":"2025","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib200","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70162","article-title":"METTL3-mediated NFAT5 Upregulation Promotes Cervical Cancer Progression Through Enhancing the Mitochondrial Function by Transcriptional Regulation of PRDX1","volume":"39","author":"He","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.semcancer.2026.102622_bib201","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1087644","article-title":"Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model","volume":"13","author":"Phan","year":"2023","journal-title":"Front. Oncol."},{"issue":"13","key":"10.1016\/j.semcancer.2026.102622_bib202","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","article-title":"Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer","volume":"83","author":"Lin","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2026.102622_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112145","article-title":"YTHDF2 drives oral squamous cell carcinoma progression via m(6)A-dependent degradation of MTUS1\/ATIP1 mRNA and mitochondrial dysregulation","volume":"136","author":"Tang","year":"2025","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib204","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12943-025-02394-8","article-title":"NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis","volume":"24","author":"Ye","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib205","first-page":"203","article-title":"m\u2075C-modified circRREB1 promotes lung cancer progression by inducing mitophagy","volume":"44","author":"Cai","year":"2025","journal-title":"Journal experimental & clinical cancer research CR"},{"key":"10.1016\/j.semcancer.2026.102622_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217266","article-title":"NSUN4-mediated m\u2075C modification of circERI3 promotes lung cancer development by altering mitochondrial energy metabolism","volume":"605","author":"Wu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.102622_bib207","first-page":"28","article-title":"Metabolic reprogramming driven by METTL1-mediated tRNA m\u2077G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma","volume":"268","author":"Chen","year":"2024","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"10.1016\/j.semcancer.2026.102622_bib208","first-page":"337","article-title":"PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma","volume":"16","author":"Lan","year":"2023","journal-title":"Pharm. Pers. Med."},{"issue":"26","key":"10.1016\/j.semcancer.2026.102622_bib209","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.7150\/thno.51231","article-title":"YTHDF1-enhanced iron metabolism depends on TFRC m(6)A methylation","volume":"10","author":"Ye","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.semcancer.2026.102622_bib210","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14591","article-title":"N(6)-methyladenosine (m(6)A) reader IGF2BP1 facilitates clear-cell renal cell carcinoma aerobic glycolysis","volume":"11","author":"Yuan","year":"2023","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib211","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12935-023-03160-w","article-title":"Identifying prognostic characteristics of m\u2076A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer","volume":"23","author":"Zhou","year":"2023","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13578-025-01368-z","article-title":"The m\u2076A revolution: transforming tumor immunity and enhancing immunotherapy outcomes","volume":"15","author":"Shi","year":"2025","journal-title":"Cell. & Biosci."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib213","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","article-title":"The role of RNA methylation in tumor immunity and its potential in immunotherapy","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2026.102622_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217566","article-title":"N(7)-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation","volume":"615","author":"Xu","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib215","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41420-024-02092-2","article-title":"Progression of m(6)A in the tumor microenvironment: hypoxia, immune and metabolic reprogramming","volume":"10","author":"Han","year":"2024","journal-title":"Cell. Death Discov."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib216","doi-asserted-by":"crossref","first-page":"916","DOI":"10.7150\/ijbs.87203","article-title":"The inhibition of YTHDF3\/m(6)A\/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer","volume":"20","author":"Zhong","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.semcancer.2026.102622_bib217","article-title":"Histone lactylation-driven YTHDC1 promotes hepatocellular carcinoma progression via lipid metabolism remodeling","volume":"611","author":"Du","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102622_bib218","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1766","article-title":"METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m(6)A modification of ANKRD22 mRNA","volume":"14","author":"Li","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib219","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1186\/s12967-023-04578-6","article-title":"ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m\u2076A-IGF2BP2-dependent manner","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13578-022-00798-3","article-title":"m\u2076A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer","volume":"12","author":"Duan","year":"2022","journal-title":"Cell. & Biosci."},{"key":"10.1016\/j.semcancer.2026.102622_bib221","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.553045","article-title":"m(6)A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1","volume":"10","author":"Guo","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib222","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/neuonc\/noad233","article-title":"Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR","volume":"26","author":"Zhang","year":"2024","journal-title":"Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib223","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-020-20379-7","article-title":"EGFR\/SRC\/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma","volume":"12","author":"Fang","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib224","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.7150\/ijbs.105391","article-title":"METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression","volume":"21","author":"Li","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s10020-025-01413-0","article-title":"Harnessing m(6)A-regulated cholesterol biosynthesis helps impede tumor burden and stemness in high-garde serous ovarian carcinoma mesenchymal phenotype","volume":"32","author":"Narayanan","year":"2025","journal-title":"Mol. Med. (Camb. Mass. )"},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib226","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41419-024-07257-6","article-title":"Stabilization of SQLE mRNA by WTAP\/FTO\/IGF2BP3-dependent manner in HGSOC: implications for metabolism, stemness, and progression","volume":"15","author":"Hou","year":"2024","journal-title":"Cell. death & Dis."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib227","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41419-025-07571-7","article-title":"IGF2BP3\/ESM1\/KLF10\/BECN1 positive feedback loop: a novel therapeutic target in ovarian cancer via lipid metabolism reprogramming","volume":"16","author":"Gao","year":"2025","journal-title":"Cell. death & Dis."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib228","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1038\/s41418-023-01223-z","article-title":"CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m\u2075C modification of ACC1 mRNA","volume":"30","author":"Zhang","year":"2023","journal-title":"Cell. death Differ."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib229","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41419-023-05646-x","article-title":"NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m(5)C methylation","volume":"14","author":"Yang","year":"2023","journal-title":"Cell. death & Dis."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib230","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240559","article-title":"tRNA m\u00b9A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells","volume":"222","author":"Miao","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.semcancer.2026.102622_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2026.112497","article-title":"From palmitoylation to cholesterol metabolism: The hidden mechanism of lung tumorigenesis","volume":"143","author":"Shen","year":"2026","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.semcancer.2026.102622_bib232","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1045","article-title":"NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells","volume":"12","author":"Dalhat","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.102622_bib233","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101934","article-title":"Exosomal NAT10 from esophageal squamous cell carcinoma cells modulates macrophage lipid metabolism and polarization through ac\u2074C modification of FASN","volume":"45","author":"Jin","year":"2024","journal-title":"Transl. Oncol."},{"issue":"Pt 2","key":"10.1016\/j.semcancer.2026.102622_bib234","article-title":"N\u00b9-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification","volume":"143","author":"Deng","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib235","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12935-025-03736-8","article-title":"The m\u2076A reader IGF2BP2 promotes pancreatic cancer progression through the m\u2076A-SLC1A5-mTORC1 axis","volume":"25","author":"Pu","year":"2025","journal-title":"Cancer Cell. Int."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib236","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell."},{"issue":"35","key":"10.1016\/j.semcancer.2026.102622_bib237","doi-asserted-by":"crossref","first-page":"21441","DOI":"10.1073\/pnas.2000516117","article-title":"The m(6)A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor","volume":"117","author":"Xiao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2026.102622_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150039","article-title":"METTL3-mediated m(6)A methylation of SLC38A1 stimulates cervical cancer growth","volume":"716","author":"Liu","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.semcancer.2026.102622_bib239","article-title":"Epigenetic Activation of PTCD3 Promotes CRC Glutamine Metabolism and Metastasis via IGF2BP2-Mediated SLC38A2 m\u2076A Modification","volume":"39","author":"Peng","year":"2025","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib240","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s13577-024-01056-z","article-title":"Cancer-associated fibroblasts-derived exosomal METTL3 promotes the proliferation, invasion, stemness and glutaminolysis in non-small cell lung cancer cells by eliciting SLC7A5 m\u2076A modification","volume":"37","author":"Fan","year":"2024","journal-title":"Human. Cell."},{"key":"10.1016\/j.semcancer.2026.102622_bib241","article-title":"NSUN2 Promotes the Growth, Metastasis and Glutamine Metabolism of Non-Small Cell Lung Cancer","author":"Zheng","year":"2025","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.semcancer.2026.102622_bib242","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.omto.2021.01.001","article-title":"Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism","volume":"20","author":"Chen","year":"2021","journal-title":"Mol. Ther. oncolytics"},{"key":"10.1016\/j.semcancer.2026.102622_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217186","article-title":"YTHDF1 regulates GID8-mediated glutamine metabolism to promote colorectal cancer progression in m\u2076A-dependent manner","volume":"601","author":"Han","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.102622_bib244","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217263","article-title":"Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathways","volume":"604","author":"Bojko","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2026.102622_bib245","article-title":"METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.102622_bib246","doi-asserted-by":"crossref","first-page":"0005","DOI":"10.34133\/cancomm.0005","article-title":"WTAP-Mediated Glutaminase Splicing Bias Suppresses Ferroptosis in Hepatocellular Carcinoma","volume":"46","author":"Zhu","year":"2026","journal-title":"Cancer communications (London England)"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib247","first-page":"5289","article-title":"IGF2BP3-mediated regulation of GLS and GLUD1 gene expression promotes treg-induced immune escape in human cervical cancer","volume":"13","author":"Zhou","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib248","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00432-025-06163-4","article-title":"NSUN5 promotes cholangiocarcinoma progression by enhancing GLS mRNA stabilization","volume":"151","author":"Shu","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.semcancer.2026.102622_bib249","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1158\/0008-5472.CAN-24-1102","article-title":"MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development","volume":"84","author":"Ding","year":"2024","journal-title":"Cancer Res."},{"issue":"35","key":"10.1016\/j.semcancer.2026.102622_bib250","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adv9401","article-title":"DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptation","volume":"11","author":"Gupta","year":"2025","journal-title":"Sci. Adv."},{"issue":"17","key":"10.1016\/j.semcancer.2026.102622_bib251","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.7150\/thno.60028","article-title":"Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.semcancer.2026.102622_bib252","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.136093","article-title":"m(6)A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expression","volume":"480","author":"Xie","year":"2024","journal-title":"J. Hazard. Mater."},{"issue":"16","key":"10.1016\/j.semcancer.2026.102622_bib253","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-23-3748","article-title":"MYLK-AS1 enhances glutamine metabolism to promote EGFR inhibitor resistance in non-small cell lung cancer","volume":"85","author":"Qu","year":"2025","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib254","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100075","article-title":"Intertwined regulation between RNA m(6)A modification and cancer metabolism","volume":"2","author":"Liu","year":"2023","journal-title":"Cell. Insight"},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib255","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s11684-024-1064-8","article-title":"Regulations of m(6)A and other RNA modifications and their roles in cancer","volume":"18","author":"Chen","year":"2024","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib256","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1097\/HEP.0000000000000420","article-title":"Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma through m 6 A-mediated epitranscriptomic regulation","volume":"78","author":"Hung","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib257","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3454","article-title":"Function and prognostic value of N\u2076-methyladenosine-modified RNAs in lung adenocarcinoma","volume":"25","author":"Liu","year":"2023","journal-title":"J. gene Med."},{"key":"10.1016\/j.semcancer.2026.102622_bib258","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1193133","article-title":"Development and validation of prognostic index based on purine metabolism genes in patients with bladder cancer","volume":"10","author":"Wu","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.semcancer.2026.102622_bib259","doi-asserted-by":"crossref","DOI":"10.20892\/j.issn.2095-3941.2025.0444","article-title":"Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer","author":"Jin","year":"2026","journal-title":"Cancer Biol. & Med."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib260","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13148-025-01956-3","article-title":"Landscape analysis of m\u2075C modification regulators unveils DNMT1-mediated dysregulated pyrimidine metabolism in hepatocellular carcinoma","volume":"17","author":"Zhao","year":"2025","journal-title":"Clin. epigenetics"},{"issue":"8","key":"10.1016\/j.semcancer.2026.102622_bib261","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113016","article-title":"Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy","volume":"42","author":"Biswas","year":"2023","journal-title":"Cell. Rep."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib262","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1007\/s12035-024-04555-0","article-title":"Global Co-regulatory Cross Talk Between m(6)A and m(5)C RNA Methylation Systems Coordinate Cellular Responses and Brain Disease Pathways","volume":"62","author":"Orji","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib263","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41467-026-68419-y","article-title":"Comprehensive mapping of RNA modification dynamics and crosstalk via deep learning and nanopore direct RNA-sequencing","volume":"17","author":"Dong","year":"2026","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib264","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41698-026-01278-4","article-title":"Integrative analysis of nanopore direct RNA sequencing data reveals a global impact of pseudouridylation on m(6)A and m(5)C modifications","volume":"10","author":"Bansal","year":"2026","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.semcancer.2026.102622_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216246","article-title":"TROP2 translation mediated by dual m(6)A\/m(7)G RNA modifications promotes bladder cancer development","volume":"566","author":"Chen","year":"2023","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib266","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cell.2024.11.007","article-title":"YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies","volume":"188","author":"Chen","year":"2025","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib267","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.molcel.2018.08.011","article-title":"Differential m(6)A, m(6)A(m), and m(1)A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm","volume":"71","author":"Wei","year":"2018","journal-title":"Mol. Cell."},{"issue":"8","key":"10.1016\/j.semcancer.2026.102622_bib268","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1073\/pnas.1820574116","article-title":"Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.semcancer.2026.102622_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111317","article-title":"m(1)A and m(6)A modifications function cooperatively to facilitate rapid mRNA degradation","volume":"40","author":"Boo","year":"2022","journal-title":"Cell. Rep."},{"issue":"33","key":"10.1016\/j.semcancer.2026.102622_bib270","article-title":"WTAP Mediated m\u2076A Modification Stabilizes PDIA3P1 and Promotes Tumor Progression Driven by Histone Lactylation in Esophageal Squamous Cell Carcinoma","volume":"12","author":"Huang","year":"2025","journal-title":"Advanced science (Weinheim Baden-Wurttemberg Germany)"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib271","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/iub.2545","article-title":"m(6) A transferase KIAA1429-stabilized LINC00958 accelerates gastric cancer aerobic glycolysis through targeting GLUT1","volume":"73","author":"Yang","year":"2021","journal-title":"IUBMB life"},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib272","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41556-026-01905-z","article-title":"The lncRNA DAMER selectively guides m\u2076A-dependent regulation of ATF4 and asparagine metabolism under nutrient stress in cancer","volume":"28","author":"Tao","year":"2026","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib273","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70577","article-title":"N\u2076-methyladenosine Modification of circIST1 Promotes Hypoxia-Inducible Factor \u03b1-mediated Glycolysis and Progression in Hepatocellular Carcinoma","volume":"7","author":"Zhan","year":"2026","journal-title":"MedComm"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib274","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.7150\/ijbs.116639","article-title":"N\u2074-acetylcytidine modification of LINC02802 promotes non-small cell lung cancer progression by modulating mitochondrial NAD+\/NADH ratio","volume":"21","author":"Yuan","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.semcancer.2026.102622_bib275","article-title":"m\u2076A Methylation Regulators METTL3 and ALKBH5 are Risk Factors for EGFR-Mutant NSCLC","volume":"32","author":"Zhi","year":"2025","journal-title":"Cancer control journal Moffitt Cancer Center"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib276","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10143-020-01238-x","article-title":"Identification of N(6)-methyladenosine-related lncRNAs for patients with primary glioblastoma","volume":"44","author":"Wang","year":"2021","journal-title":"Neurosurg. Rev."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib277","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/j.ymthe.2024.10.025","article-title":"N\u2076-methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer","volume":"32","author":"Chan","year":"2024","journal-title":"Molecular therapy journal American Society Gene Therapy"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib278","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384101.2026.2665248","article-title":"Metformin counteracts lipid accumulation and cell proliferation in hepatocellular carcinoma via regulating METTL3-mediated m(6)A methylation","volume":"25","author":"Qi","year":"2026","journal-title":"Cell cycle (Georgetown Tex. )"},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib279","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/0008-5472.CAN-24-1630","article-title":"Energy Stress-Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma","volume":"85","author":"Yang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2026.102622_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215815","article-title":"N\u2076-methyladenosine modification and metabolic reprogramming of digestive system malignancies","volume":"544","author":"Cai","year":"2022","journal-title":"Cancer Lett."},{"issue":"38","key":"10.1016\/j.semcancer.2026.102622_bib281","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.3748\/wjg.v30.i38.4175","article-title":"Modulation of host N\u2076-methyladenosine modification by gut microbiota in colorectal cancer","volume":"30","author":"Jiang","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2026.102622_bib282","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1464042","article-title":"N\u2076-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2026.102622_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123965","article-title":"Reprogramming cysteine metabolism via METTL14-SLC7A11 axis promotes the progression of NAFLD and hepatocellular carcinoma","volume":"380","author":"He","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.semcancer.2026.102622_bib284","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1169168","article-title":"Metabolo-epigenetic interplay provides targeted nutritional interventions in chronic diseases and ageing","volume":"13","author":"G\u00f3mez de Cedr\u00f3n","year":"2023","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib285","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030535","article-title":"S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy","volume":"17","author":"Fern\u00e1ndez-Ramos","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib286","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1038\/s41467-025-59119-0","article-title":"PRPS2 enhances RNA m(6)A methylation by stimulating SAM synthesis through enzyme-dependent and independent mechanisms","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib287","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41418-024-01285-7","article-title":"Unveiling the methionine cycle: a key metabolic signature and NR4A2 as a methionine-responsive oncogene in esophageal squamous cell carcinoma","volume":"31","author":"Jin","year":"2024","journal-title":"Cell. death Differ."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib288","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41422-025-01213-5","article-title":"The AHCY-adenosine complex rewires mRNA methylation to enhance fatty acid biosynthesis and tumorigenesis","volume":"36","author":"Liao","year":"2026","journal-title":"Cell. Res."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib289","doi-asserted-by":"crossref","first-page":"837","DOI":"10.4049\/immunohorizons.2200086","article-title":"Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-Talk","volume":"6","author":"Greenwood","year":"2022","journal-title":"ImmunoHorizons"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib290","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tcb.2020.09.010","article-title":"Metabolic Coordination of Cell Fate by \u03b1-Ketoglutarate-Dependent Dioxygenases","volume":"31","author":"Baksh","year":"2021","journal-title":"Trends Cell. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib291","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13148-020-00848-y","article-title":"Dysregulation of 2-oxoglutarate-dependent dioxygenases by hyperglycaemia: does this link diabetes and vascular disease?","volume":"12","author":"Green","year":"2020","journal-title":"Clin. epigenetics"},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib292","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00395-025-01135-8","article-title":"Alpha-ketoglutarate protects against myocardial infarction via FTO-mediated anti-inflammatory macrophage activation","volume":"120","author":"Lin","year":"2025","journal-title":"Basic. Res. Cardiol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib293","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcae004","article-title":"Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma","volume":"6","author":"Fitzsimmons","year":"2024","journal-title":"NAR Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib294","first-page":"41","article-title":"Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO\/m(6)A\/ANGPTL4\/integrin axis in triple-negative breast cancer","volume":"44","author":"Zhang","year":"2025","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"13","key":"10.1016\/j.semcancer.2026.102622_bib295","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1038\/s44318-024-00100-w","article-title":"The immune response to RNA suppresses nucleic acid synthesis by limiting ribose 5-phosphate","volume":"43","author":"Bhattacharjee","year":"2024","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib296","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11033-023-09076-y","article-title":"D-ribose metabolic disorder and diabetes mellitus","volume":"51","author":"Tai","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib297","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1566524020666200521075252","article-title":"Metabolic Ink Lactate Modulates Epigenomic Landscape: A Concerted Role of Pro-tumor Microenvironment and Macroenvironment During Carcinogenesis","volume":"21","author":"Sharma","year":"2021","journal-title":"Curr. Mol. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib298","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2025.13456","article-title":"Potential of lactylation as a therapeutic target in cancer treatment (Review)","volume":"31","author":"Zhu","year":"2025","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib299","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2026.102622_bib300","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218282","article-title":"Lactylation enhances YTHDF3 stability to promote cisplatin resistance via m\u2076A-dependent KDM6B decay in bladder cancer","volume":"642","author":"Yu","year":"2026","journal-title":"Cancer Lett."},{"issue":"46","key":"10.1016\/j.semcancer.2026.102622_bib301","article-title":"Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m\u2076A-Modification Promotes Lenvatinib Resistance in HCC","volume":"11","author":"Lu","year":"2024","journal-title":"Advanced science (Weinheim Baden-Wurttemberg Germany)"},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib302","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.7150\/thno.122294","article-title":"Lactylation-driven NSUN2-mediated RNA m\u2075C modification promotes perineural invasion in pancreatic cancer","volume":"16","author":"Huang","year":"2026","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.semcancer.2026.102622_bib303","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.cmet.2025.07.008","article-title":"Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development","volume":"37","author":"Liu","year":"2025","journal-title":"Cell. Metab."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib304","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11020080","article-title":"Metabolic Control of m(6)A RNA Modification","volume":"11","author":"Kim","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40364-023-00483-8","article-title":"Functions of N\u2076-methyladenosine in cancer metabolism: from mechanism to targeted therapy","volume":"11","author":"He","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.semcancer.2026.102622_bib306","article-title":"m\u2076A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges","volume":"15","author":"Yan","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib307","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1186\/s12967-025-06985-3","article-title":"m\u2075C RNA modification in colorectal cancer: mechanisms and therapeutic targets","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.102622_bib308","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.736298","article-title":"N(6)-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors","volume":"9","author":"Zhan","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib309","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i5.104076","article-title":"Switching from messenger RNAs to noncoding RNAs, METTL3 is a novel colorectal cancer diagnosis and treatment target","volume":"17","author":"Liao","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib310","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/pharmaceutics13040544","article-title":"Delivery of Oligonucleotides Using a Self-Degradable Lipid-Like Material","volume":"13","author":"Tanaka","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.semcancer.2026.102622_bib311","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.711815","article-title":"Effect, Mechanism, and Applications of Coding\/Non-Coding RNA m\u2076A Modification in Tumor Microenvironment","volume":"9","author":"Si","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.semcancer.2026.102622_bib312","article-title":"Non-Coding RNA m\u2076A Modification in Cancer: Mechanisms and Therapeutic Targets","volume":"9","author":"Da-hong","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"13-14","key":"10.1016\/j.semcancer.2026.102622_bib313","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1101\/gad.348320.121","article-title":"Targeting the m\u2076A RNA Modification Pathway Blocks SARS-CoV-2 and HCoV-OC43 Replication","volume":"35","author":"Burgess","year":"2021","journal-title":"Genes. & Dev."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib314","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0129-x","article-title":"N\u2076-methyladenosine Links RNA Metabolism to Cancer Progression","volume":"9","author":"Dai","year":"2018","journal-title":"Cell. Death Dis."},{"issue":"13","key":"10.1016\/j.semcancer.2026.102622_bib315","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1158\/0008-5472.CAN-20-4107","article-title":"The Emerging Roles of RNA m\u2076A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance","volume":"81","author":"Lan","year":"2021","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib316","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1038\/s41375-025-02765-6","article-title":"Epitranscriptomic advances in normal and malignant hematopoiesis","volume":"39","author":"Eleftheriou","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2026.102622_bib317","article-title":"Main N\u2076-methyladenosine Readers: YTH Family Proteins in Cancers","volume":"11","author":"Dai","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102622_bib318","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.7150\/ijbs.70458","article-title":"The Role of Insulin-Like Growth Factor 2 mRNA-binding Proteins (IGF2BPs) as M<sup>6<\/Sup>A Readers in Cancer","volume":"18","author":"Sun","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib319","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell."},{"issue":"15","key":"10.1016\/j.semcancer.2026.102622_bib320","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.7150\/ijbs.77774","article-title":"FTO-mediated Autophagy Promotes Progression of Clear Cell Renal Cell Carcinoma via Regulating SIK2 mRNA Stability","volume":"18","author":"Xu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102622_bib321","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/cjoc.202100901","article-title":"A Rhein-Based Rh(III) Arene Complex With Anti-tumor Cell Proliferative Activity Inhibits RNA Demethylase FTO","volume":"40","author":"Liu","year":"2022","journal-title":"Chin. J. Chem."},{"issue":"15","key":"10.1016\/j.semcancer.2026.102622_bib322","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400545R","article-title":"Targeted Inhibition of m\u2076A Demethylase FTO by FB23 Attenuates Allergic Inflammation in the Airway Epithelium","volume":"38","author":"Lian","year":"2024","journal-title":"Faseb J."},{"issue":"9","key":"10.1016\/j.semcancer.2026.102622_bib323","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2217\/epi-2019-0358","article-title":"RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy","volume":"12","author":"Xiang","year":"2020","journal-title":"Epigenomics"},{"key":"10.1016\/j.semcancer.2026.102622_bib324","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177397","article-title":"Pharmacology of epitranscriptomic modifications: Decoding the therapeutic potential of RNA modifications in drug resistance","volume":"994","author":"Alkhammash","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib325","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.tranon.2017.07.008","article-title":"A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation","volume":"10","author":"Mahapatra","year":"2017","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib326","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gutjnl-2019-318918","article-title":"Targeting Clinical Epigenetic Reprogramming for Chemoprevention of Metabolic and Viral Hepatocellular Carcinoma","volume":"70","author":"J\u00fchling","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib327","doi-asserted-by":"crossref","DOI":"10.1186\/1868-7083-3-8","article-title":"Ribavirin Restores ESR1 Gene Expression and Tamoxifen Sensitivity in ESR1 Negative Breast Cancer Cell Lines","volume":"3","author":"Sappok","year":"2011","journal-title":"Clin. Epigenetics"},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib328","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/genes10020102","article-title":"Eukaryotic 5-Methylcytosine (m\u2075C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease","volume":"10","author":"Bohnsack","year":"2019","journal-title":"Genes"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib329","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202211358","article-title":"Machine Learning Informs RNA-Binding Chemical Space","volume":"62","author":"Yazdani","year":"2023","journal-title":"Angew. Chem."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib330","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1021\/acschembio.6b00001","article-title":"Inforna 2.0: A Platform for the Sequence-Based Design of Small Molecules Targeting Structured RNAs","volume":"11","author":"Disney","year":"2016","journal-title":"Acs Chem. Biol."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib331","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nchembio.1452","article-title":"Sequence-Based Design of Bioactive Small Molecules That Target Precursor microRNAs","volume":"10","author":"Velagapudi","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.semcancer.2026.102622_bib332","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05075-2","article-title":"RNA-based Therapeutics: An Overview and Prospectus","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell. Death Dis."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib333","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41594-018-0054-4","article-title":"Tapping the RNA World for Therapeutics","volume":"25","author":"Lieberman","year":"2018","journal-title":"Nat. Struct. & Mol. Biol."},{"issue":"20","key":"10.1016\/j.semcancer.2026.102622_bib334","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","article-title":"Lipids and Lipid Derivatives for RNA Delivery","volume":"121","author":"Zhang","year":"2021","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib335","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27493-0","article-title":"An Ionizable Lipid Toolbox for RNA Delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.semcancer.2026.102622_bib336","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1021\/acs.nanolett.1c01973","article-title":"Lipid Nanoparticle Spherical Nucleic Acids for Intracellular DNA and RNA Delivery","volume":"21","author":"Sinegra","year":"2021","journal-title":"Nano Lett."},{"issue":"19","key":"10.1016\/j.semcancer.2026.102622_bib337","article-title":"Therapeutic Gene Silencing Using Targeted Lipid Nanoparticles in Metastatic Ovarian Cancer","volume":"17","author":"Singh","year":"2021","journal-title":"Small"},{"issue":"6481","key":"10.1016\/j.semcancer.2026.102622_bib338","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T Cells in Patients With Refractory Cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.semcancer.2026.102622_bib339","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1111\/cas.15554","article-title":"Cancerous pH-responsive Polycarboxybetaine-coated Lipid Nanoparticle for Smart Delivery of siRNA Against Subcutaneous Tumor Model in Mice","volume":"113","author":"Sung","year":"2022","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib340","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s12672-025-03383-5","article-title":"CRISPR\/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook","volume":"16","author":"Noormohamadi","year":"2025","journal-title":"Discov. Oncol."},{"issue":"15","key":"10.1016\/j.semcancer.2026.102622_bib341","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41388-024-02975-9","article-title":"Dissecting the oncogenic properties of essential RNA-modifying enzymes: a focus on NAT10","volume":"43","author":"Dalhat","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2026.102622_bib342","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164933","article-title":"Biosynthesis and bioassays of multifunctional S-adenosylmethionine: A comprehensive review","volume":"519","author":"Cheng","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib343","article-title":"The Diagnostic Value of Lower Glucose Consumption for IDH1 Mutated Gliomas on FDG-PET","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Cancer"},{"issue":"13","key":"10.1016\/j.semcancer.2026.102622_bib344","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.3390\/cancers15133307","article-title":"The Regulation of m\u2076A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches","volume":"15","author":"Deacon","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib345","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70102","article-title":"Reviewing the IDH1 Mutation-Mediated Mechanism of Drug Resistance and Revisiting Its Overcoming Strategies","volume":"105","author":"Wang","year":"2025","journal-title":"Chem. Biol. & Drug. Des."},{"issue":"4","key":"10.1016\/j.semcancer.2026.102622_bib346","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1042\/BST20230017","article-title":"The Curious Case of IDH Mutant Acute Myeloid Leukaemia: Biochemistry and Therapeutic Approaches","volume":"51","author":"Gruber","year":"2023","journal-title":"Biochem. Soc. Trans."},{"issue":"19","key":"10.1016\/j.semcancer.2026.102622_bib347","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1038\/s41388-022-02312-y","article-title":"Targeting Oncometabolism to Maximize Immunotherapy in Malignant Brain Tumors","volume":"41","author":"Bernstock","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2026.102622_bib348","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.982424","article-title":"Recent Advances of IDH1 Mutant Inhibitor in Cancer Therapy","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib349","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imcb.12620","article-title":"The regulation of N\u2076-methyladenosine modification in PD-L1-induced anti-tumor immunity","volume":"101","author":"Yu","year":"2023","journal-title":"Immunol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2026.102622_bib350","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1583","article-title":"LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m(6) A modification in triple-negative breast cancer","volume":"14","author":"Yu","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.semcancer.2026.102622_bib351","article-title":"Targeting intracellular mRNA m(6)A-modifiers in advancing immunotherapeutics","author":"Kumar","year":"2025","journal-title":"J. Adv. Res."},{"issue":"10","key":"10.1016\/j.semcancer.2026.102622_bib352","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.3390\/ijms23105654","article-title":"The Advances in Epigenetics for Cancer Radiotherapy","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib353","first-page":"497","article-title":"Latest Findings on the Function of Immune Metabolism in Tumor Immunity], Sichuan da xue xue bao","volume":"54","author":"Yang","year":"2023","journal-title":"Yi xue Ban. = J. Sichuan Univ. Med. Sci. Ed."},{"key":"10.1016\/j.semcancer.2026.102622_bib354","article-title":"A novel strategy to fuel cancer immunotherapy: targeting glucose metabolism to remodel the tumor microenvironment","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2026.102622_bib355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1578940","article-title":"Glutamine's double-edged sword: fueling tumor growth and offering therapeutic hope","volume":"16","author":"Fang","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib356","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11684-023-1025-7","article-title":"Metabolic interventions combined with CTLA-4 and PD-1\/PD-L1 blockade for the treatment of tumors: mechanisms and strategies","volume":"17","author":"Liao","year":"2023","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib357","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061502","article-title":"Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors","volume":"12","author":"Peyraud","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2026.102622_bib358","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.actbio.2022.04.027","article-title":"Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy","volume":"146","author":"Ding","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.semcancer.2026.102622_bib359","first-page":"634","article-title":"Nanostrategies synergize with locoregional interventional therapies for boosting antitumor immunity","volume":"51","author":"Luo","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.semcancer.2026.102622_bib360","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.actbio.2025.02.008","article-title":"Copper-doped layered double hydroxides co-deliver proteins\/drugs for cascaded chemodynamic\/immunotherapy via dual regulation of tumor metabolism","volume":"195","author":"Li","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.semcancer.2026.102622_bib361","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114378","article-title":"Macrophage-targeting combination therapy enhances T-DXd-induced tumor regression","volume":"152","author":"Li","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib362","article-title":"METTL3-Driven m\u2076A Modification of Cpt1a Gene in High Fat Diet Related Liver Cancer Tumor Macrophages Facilitates Type II Macrophage Differentiation","volume":"30","author":"Zhu","year":"2025","journal-title":"Front. Biosci. (Landmark Ed. )"},{"issue":"22","key":"10.1016\/j.semcancer.2026.102622_bib363","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225810","article-title":"Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies","volume":"13","author":"Alkaraki","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib364","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tem.2023.11.005","article-title":"Metabolic challengers selecting tumor-persistent cells","volume":"35","author":"Mancini","year":"2024","journal-title":"Trends Endocrinol. Metab. TEM"},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib365","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.chembiol.2024.02.001","article-title":"Metabolic rewiring and communication in cancer immunity","volume":"31","author":"Chapman","year":"2024","journal-title":"Cell. Chem. Biol."},{"issue":"19","key":"10.1016\/j.semcancer.2026.102622_bib366","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910268","article-title":"Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy","volume":"22","author":"Yan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib367","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189422","article-title":"Targeting cholesterol metabolism in tumor and its immune microenvironment: opportunities and challenges","volume":"1880","author":"Wang","year":"2025","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib368","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.7150\/thno.105276","article-title":"Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib369","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167164","article-title":"Metabolic adaptations in cancer stem cells: A key to therapy resistance","volume":"1870","author":"Masoudi","year":"2024","journal-title":"Biochim. Et. Biophys. Acta Mol. basis Dis."},{"issue":"14","key":"10.1016\/j.semcancer.2026.102622_bib370","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.7150\/thno.42523","article-title":"Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer","volume":"10","author":"Ravindran Menon","year":"2020","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.semcancer.2026.102622_bib371","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s12015-025-10956-y","article-title":"Metabolic Plasticity and Cancer Stem Cell Metabolism: Exploring the Glycolysis-OXPHOS Switch as a Mechanism for Resistance and Tumorigenesis","volume":"21","author":"Keoh","year":"2025","journal-title":"Stem Cell. Rev. Rep."},{"key":"10.1016\/j.semcancer.2026.102622_bib372","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1254313","article-title":"Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations","volume":"11","author":"Pendleton","year":"2023","journal-title":"Front. Cell. Dev. Biol."},{"issue":"13-15","key":"10.1016\/j.semcancer.2026.102622_bib373","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/ars.2022.0088","article-title":"Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance","volume":"39","author":"Bailleul","year":"2023","journal-title":"Antioxid. & Redox Signal."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib374","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41420-025-02670-y","article-title":"Mitochondrial metabolic reprogramming in colorectal cancer: mechanisms of resistance and future clinical interventions","volume":"11","author":"Qiu","year":"2025","journal-title":"Cell. death Discov."},{"key":"10.1016\/j.semcancer.2026.102622_bib375","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3389\/fonc.2020.01692","article-title":"Manipulation of Mitochondrial Plasticity Changes the Metabolic Competition Between \"Foe\" and \"Friend\" During Tumor Malignant Transformation","volume":"10","author":"Tian","year":"2020","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.semcancer.2026.102622_bib376","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","article-title":"The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity","volume":"13","author":"Davies","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2026.102622_bib377","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcdb.2023.11.003","article-title":"Persister cell plasticity in tumour drug resistance","volume":"156","author":"McDonald","year":"2024","journal-title":"Semin. Cell. & Dev. Biol."},{"issue":"8022","key":"10.1016\/j.semcancer.2026.102622_bib378","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41586-024-07690-9","article-title":"Cellular adaptation to cancer therapy along a resistance continuum","volume":"631","author":"Fran\u00e7a","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2026.102622_bib379","first-page":"1","article-title":"Crosstalk of Eight Types of RNA Modification Regulators Defines Tumor Microenvironments, Cancer Hallmarks, and Prognosis of Lung Adenocarcinoma","author":"Mao","year":"2022","journal-title":"J. Oncol. 2022"},{"key":"10.1016\/j.semcancer.2026.102622_bib380","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.777007","article-title":"Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention Strategies","volume":"9","author":"Zhu","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2026.102622_bib381","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/1541-7786.MCR-22-0451","article-title":"Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor-Positive Breast Cancer","volume":"21","author":"Buschhaus","year":"2023","journal-title":"Molecular cancer research MCR"},{"key":"10.1016\/j.semcancer.2026.102622_bib382","first-page":"493","article-title":"A micro-metabolic rewiring assay for assessing hypoxia-associated cancer metabolic heterogeneity","volume":"48","author":"Oh","year":"2025","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib383","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"8-9","key":"10.1016\/j.semcancer.2026.102622_bib384","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/carcin\/bgad058","article-title":"On the road to colorectal cancer development: crosstalk between the gut microbiota, metabolic reprogramming, and epigenetic modifications","volume":"44","author":"Chen","year":"2023","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.semcancer.2026.102622_bib385","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41416-025-02969-8","article-title":"The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics","volume":"132","author":"Lin","year":"2025","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.semcancer.2026.102622_bib386","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.7150\/thno.52366","article-title":"N(6)-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.semcancer.2026.102622_bib387","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.7150\/ijbs.60641","article-title":"The interplay between m\u2076A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications","volume":"17","author":"Qin","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.semcancer.2026.102622_bib388","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1005693","article-title":"Novel insights into the N 6-methyladenosine modification on circRNA in cancer","volume":"15","author":"Xu","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib389","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12920-024-01975-8","article-title":"Biomarkers related to m\u2076A and succinic acid metabolism in papillary thyroid carcinoma","volume":"17","author":"Li","year":"2024","journal-title":"BMC Med. Genom."},{"issue":"9","key":"10.1016\/j.semcancer.2026.102622_bib390","first-page":"759","article-title":"Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer, Drug metabolism and disposition: the biological fate of","volume":"48","author":"Wang","year":"2020","journal-title":"chemicals"},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib391","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2223382","article-title":"Molecular Features, Biological Behaviors and Clinical Implications of M 5C RNA Methylation Modification Regulators in Gastrointestinal Cancers","volume":"24","author":"Zhan","year":"2023","journal-title":"Cancer Biol. & Ther."},{"issue":"1","key":"10.1016\/j.semcancer.2026.102622_bib392","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2643-3249.BCD-20-0032","article-title":"Epitranscriptomics in Hematopoiesis and Hematologic Malignancies","volume":"1","author":"Rossell\u00f3-Tortella","year":"2020","journal-title":"Blood Cancer Discov."},{"issue":"3","key":"10.1016\/j.semcancer.2026.102622_bib393","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70135","article-title":"RNA Modification in Metabolism","volume":"6","author":"Liu","year":"2025","journal-title":"Medcomm"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X26000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:16:29Z","timestamp":1791663389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X26000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":393,"alternative-id":["S1044579X26000891"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.102622","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNA modifications and metabolism in cancer: Mechanisms, cross-talk and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2026.102622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102622"}}